Literature DB >> 9006003

Podocyte loss and progressive glomerular injury in type II diabetes.

M E Pagtalunan1, P L Miller, S Jumping-Eagle, R G Nelson, B D Myers, H G Rennke, N S Coplon, L Sun, T W Meyer.   

Abstract

Kidney biopsies from Pima Indians with type II diabetes were analyzed. Subjects were classified clinically as having early diabetes (n = 10), microalbuminuria (n = 17), normoalbuminuria, despite a duration of diabetes equal to that of the subjects with microalbuminuria (n = 12), or clinical nephropathy (n = 12). Subjects with microalbuminuria exhibited moderate increases in glomerular and mesangial volume when compared with those with early diabetes, but could not be distinguished from subjects who remained normoalbuminuric after an equal duration of diabetes. Subjects with clinical nephropathy exhibited global glomerular sclerosis and more prominent structural abnormalities in nonsclerosed glomeruli. Marked mesangial expansion was accompanied by a further increase in total glomerular volume. Glomerular capillary surface area remained stable, but the glomerular basement membrane thickness was increased and podocyte foot processes were broadened. Broadening of podocyte foot processes was associated with a reduction in the number of podocytes per glomerulus and an increase in the surface area covered by remaining podocytes. These findings suggest that podocyte loss contributes to the progression of diabetic nephropathy.

Entities:  

Mesh:

Year:  1997        PMID: 9006003      PMCID: PMC507802          DOI: 10.1172/JCI119163

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Glomerular size and structure in diabetes mellitus. III. Early enlargement of the capillary surface.

Authors:  J P Kroustrup; H J Gundersen; R Osterby
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

Review 2.  Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?

Authors:  C E Mogensen
Journal:  Diabetes       Date:  1990-07       Impact factor: 9.461

3.  Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.

Authors:  J W Fries; D J Sandstrom; T W Meyer; H G Rennke
Journal:  Lab Invest       Date:  1989-02       Impact factor: 5.662

4.  Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians.

Authors:  C L Kunzelman; W C Knowler; D J Pettitt; P H Bennett
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

5.  Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria.

Authors:  B M Chavers; R W Bilous; E N Ellis; M W Steffes; S M Mauer
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

6.  Glomerular hemodynamics in experimental diabetes mellitus.

Authors:  T H Hostetter; J L Troy; B M Brenner
Journal:  Kidney Int       Date:  1981-03       Impact factor: 10.612

7.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  Fast accumulation of basement membrane material and the rate of morphological changes in acute experimental diabetic glomerular hypertrophy.

Authors:  R Osterby; H J Gundersen
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

9.  A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy.

Authors:  R Osterby; H H Parving; G Nyberg; E Hommel; H E Jørgensen; H Løkkegaard; C Svalander
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

10.  Atubular glomeruli in patients with chronic allograft rejection.

Authors:  M E Pagtalunan; R Oberbauer; M Haas; M Barlan; G Mayer; J L Olson; T W Meyer
Journal:  Transplantation       Date:  1996-04-27       Impact factor: 4.939

View more
  384 in total

Review 1.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

2.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

3.  Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Authors:  Putri A Agustian; Mario Schiffer; Wilfried Gwinner; Irini Schäfer; Katharina Theophile; Friedrich Modde; Clemens L Bockmeyer; Jana Traeder; Ulrich Lehmann; Anika Grosshennig; Hans H Kreipe; Verena Bröcker; Jan U Becker
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 4.  The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm.

Authors:  S G Adler; C C Nast
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

5.  Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury.

Authors:  Alison L Kent; Linda Brown; Margaret Broom; Amy Broomfield; Jane E Dahlstrom
Journal:  Pediatr Nephrol       Date:  2012-03-14       Impact factor: 3.714

6.  Indomethacin, ibuprofen and gentamicin administered during late stages of glomerulogenesis do not reduce glomerular number at 14 days of age in the neonatal rat.

Authors:  Alison L Kent; Rebecca Douglas-Denton; Bruce Shadbolt; Jane E Dahlstrom; Lesley E Maxwell; Mark E Koina; Michael C Falk; David Willenborg; John F Bertram
Journal:  Pediatr Nephrol       Date:  2009-02-24       Impact factor: 3.714

Review 7.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

8.  A novel mouse model of podocyte depletion.

Authors:  L Wang; Y Tang; D N Howell; P Ruiz; R F Spurney
Journal:  Nephron Exp Nephrol       Date:  2012-10-19

9.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Authors:  Adam Whaley-Connell; Ravi Nistala; Javad Habibi; Melvin R Hayden; Rebecca I Schneider; Megan S Johnson; Roger Tilmon; Nathan Rehmer; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.